Growing community of inventors

Ammerbuch, Germany

Markus Loeffler

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Markus LoefflerDaniel Johannes Kowalewski (9 patents)Markus LoefflerHans-Georg Rammensee (9 patents)Markus LoefflerStefan Stevanovic (9 patents)Markus LoefflerJuliane Sarah Walz (9 patents)Markus LoefflerMoreno Di Marco (9 patents)Markus LoefflerSebastian Haen (9 patents)Markus LoefflerNico Trautwein (9 patents)Markus LoefflerAnnika Nelde (9 patents)Markus LoefflerMarkus Loeffler (9 patents)Daniel Johannes KowalewskiDaniel Johannes Kowalewski (159 patents)Hans-Georg RammenseeHans-Georg Rammensee (68 patents)Stefan StevanovicStefan Stevanovic (51 patents)Juliane Sarah WalzJuliane Sarah Walz (25 patents)Moreno Di MarcoMoreno Di Marco (10 patents)Sebastian HaenSebastian Haen (10 patents)Nico TrautweinNico Trautwein (10 patents)Annika NeldeAnnika Nelde (10 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Immatics Biotechnologies Gmbh (9 from 725 patents)


9 patents:

1. 11559550 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

2. 11560405 - Peptides and combination thereof for use in the immunotherapy against cancers

3. 11542303 - Peptides and combination thereof for use in the immunotherapy against cancers

4. 11427614 - Peptides and combination thereof for use in the immunotherapy against cancers

5. 11135246 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

6. 11103534 - Peptides and combination thereof for use in the immunotherapy against cancers

7. 11020432 - Peptides and combination thereof for use in the immunotherapy against cancers

8. 11007223 - Peptides and combination thereof for use in the immunotherapy against cancers

9. 10993963 - Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/12/2026
Loading…